PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.54
ESG score 80-90% of CGTX's 70.90. Walter Schloss would scrutinize governance quality and regulatory exposure.
57.89
Environmental score below 80% of CGTX's 74.45. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
58.17
Social score 90-95% of CGTX's 63.52. Bill Ackman would demand clear social improvement catalysts.
56.57
Governance score below 80% of CGTX's 74.72. Jim Chanos would check for potential agency conflicts and oversight failures.